1966 related articles for article (PubMed ID: 22074667)
21. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
22. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.
Basch E; Abernethy AP; Mullins CD; Reeve BB; Smith ML; Coons SJ; Sloan J; Wenzel K; Chauhan C; Eppard W; Frank ES; Lipscomb J; Raymond SA; Spencer M; Tunis S
J Clin Oncol; 2012 Dec; 30(34):4249-55. PubMed ID: 23071244
[TBL] [Abstract][Full Text] [Related]
23. PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH.
Moloney R; Mohr P; Hawe E; Shah K; Garau M; Towse A
Int J Technol Assess Health Care; 2015 Jan; 31(1-2):90-8. PubMed ID: 26168804
[TBL] [Abstract][Full Text] [Related]
24. The implications of comparative effectiveness research for academic medicine.
Rich EC; Bonham AC; Kirch DG
Acad Med; 2011 Jun; 86(6):684-8. PubMed ID: 21512362
[TBL] [Abstract][Full Text] [Related]
25. Scientific and organizational collaboration in comparative effectiveness research: the VA cooperative studies program model.
Huang GD; Ferguson RE; Peduzzi PN; O'Leary TJ
Am J Med; 2010 Dec; 123(12 Suppl 1):e24-31. PubMed ID: 21184863
[TBL] [Abstract][Full Text] [Related]
26. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
[TBL] [Abstract][Full Text] [Related]
27. Observational study designs for comparative effectiveness research: an alternative approach to close evidence gaps in head-and-neck cancer.
Goulart BH; Ramsey SD; Parvathaneni U
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):106-14. PubMed ID: 24331656
[TBL] [Abstract][Full Text] [Related]
28. Challenges in using electronic health record data for CER: experience of 4 learning organizations and solutions applied.
Bayley KB; Belnap T; Savitz L; Masica AL; Shah N; Fleming NS
Med Care; 2013 Aug; 51(8 Suppl 3):S80-6. PubMed ID: 23774512
[TBL] [Abstract][Full Text] [Related]
29. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
30. An overview of methods for comparative effectiveness research.
Meyer AM; Wheeler SB; Weinberger M; Chen RC; Carpenter WR
Semin Radiat Oncol; 2014 Jan; 24(1):5-13. PubMed ID: 24314337
[TBL] [Abstract][Full Text] [Related]
31. A call for action: Comparative effectiveness research in asthma.
Krishnan JA; Schatz M; Apter AJ
J Allergy Clin Immunol; 2011 Jan; 127(1):123-7. PubMed ID: 20855111
[TBL] [Abstract][Full Text] [Related]
32. Recent controversies on comparative effectiveness research investigations: Challenges, opportunities, and pitfalls.
Kirpalani H; Truog WE; D'Angio CT; Cotten M
Semin Perinatol; 2016 Oct; 40(6):341-347. PubMed ID: 27423511
[TBL] [Abstract][Full Text] [Related]
33. Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges.
Perfetto EM; Anyanwu C; Pickering MK; Zaghab RW; Graff JS; Eichelberger B
J Manag Care Spec Pharm; 2016 Jun; 22(6):609-16. PubMed ID: 27231789
[TBL] [Abstract][Full Text] [Related]
34. Leveraging observational registries to inform comparative effectiveness research.
Shah BR; Drozda J; Peterson ED
Am Heart J; 2010 Jul; 160(1):8-15. PubMed ID: 20598966
[TBL] [Abstract][Full Text] [Related]
35. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
36. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective.
Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI)
JAMA; 2012 Apr; 307(15):1636-40. PubMed ID: 22511692
[TBL] [Abstract][Full Text] [Related]
37. A translation table for patient-centered comparative effectiveness research: guidance to improve the value of research for clinical and health policy decision-making.
Tunis SR; Messner DA; Mohr P; Gliklich RE; Dubois RW
J Comp Eff Res; 2012 May; 1(3):259-62. PubMed ID: 24237407
[TBL] [Abstract][Full Text] [Related]
38. CER Hub: An informatics platform for conducting comparative effectiveness research using multi-institutional, heterogeneous, electronic clinical data.
Hazlehurst BL; Kurtz SE; Masica A; Stevens VJ; McBurnie MA; Puro JE; Vijayadeva V; Au DH; Brannon ED; Sittig DF
Int J Med Inform; 2015 Oct; 84(10):763-73. PubMed ID: 26138036
[TBL] [Abstract][Full Text] [Related]
39. Deciding what type of evidence and outcomes to include in guidelines: article 5 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Wilt TJ; Guyatt G; Kunz R; Macnee W; Puhan MA; Viegi G; Woodhead M; Akl EA; Schünemann HJ;
Proc Am Thorac Soc; 2012 Dec; 9(5):243-50. PubMed ID: 23256166
[TBL] [Abstract][Full Text] [Related]
40. Practical guide to understanding Comparative Effectiveness Research (CER).
Neely JG; Sharon JD; Graboyes EM; Paniello RC; Nussenbaum B; Grindler DJ; Dassopoulos T;
Otolaryngol Head Neck Surg; 2013 Dec; 149(6):804-12. PubMed ID: 24098005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
